In Vitro-In Vivo Correlation of Posaconazole-Amphotericin B Combination against

Candida albicans amphotericin B combination therapy in vitro–in vivo correlation posaconazole

Journal

Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827

Informations de publication

Date de publication:
01 Apr 2023
Historique:
received: 25 02 2023
revised: 27 03 2023
accepted: 29 03 2023
medline: 28 4 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

The in vitro/in vivo correlation of antifungal combination testing is necessary in order to assess the efficacy of combination regimens. We, therefore, attempted to correlate in vitro chequerboard testing of posaconazole (POS) and amphotericin B (AMB) with the in vivo outcome of combination therapy against experimental candidiasis in a neutropenic murine model. The AMB + POS combination was tested against a

Identifiants

pubmed: 37108889
pii: jof9040434
doi: 10.3390/jof9040434
pmc: PMC10146624
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Antimicrob Agents Chemother. 2004 Mar;48(3):693-715
pubmed: 14982754
Antimicrob Agents Chemother. 1999 Dec;43(12):2841-7
pubmed: 10582869
Oncology (Williston Park). 2004 Nov;18(13 Suppl 7):24-9
pubmed: 15651179
Med Mycol. 2005 Mar;43(2):133-52
pubmed: 15832557
Antimicrob Agents Chemother. 1996 Mar;40(3):609-12
pubmed: 8851579
J Antimicrob Chemother. 2003 Jul;52(1):1
pubmed: 12805255
Antimicrob Agents Chemother. 2015 Jul;59(7):3973-83
pubmed: 25896699
J Fungi (Basel). 2022 Oct 13;8(10):
pubmed: 36294642
Antimicrob Agents Chemother. 2010 Feb;54(2):602-9
pubmed: 19995928
J Antimicrob Chemother. 2016 Nov;71(11):3135-3147
pubmed: 27494912
Antimicrob Agents Chemother. 2004 Jan;48(1):137-42
pubmed: 14693531
Antimicrob Agents Chemother. 1997 Jun;41(6):1345-8
pubmed: 9174196
Biochim Biophys Acta. 1992 Jul 8;1108(1):49-58
pubmed: 1643081
Antimicrob Agents Chemother. 2001 Feb;45(2):485-94
pubmed: 11158745
J Fungi (Basel). 2022 Sep 16;8(9):
pubmed: 36135692
Antimicrob Agents Chemother. 2001 Mar;45(3):922-6
pubmed: 11181381
Int J Antimicrob Agents. 2006 Nov;28(5):439-49
pubmed: 17055706
Antimicrob Agents Chemother. 2010 Feb;54(2):860-5
pubmed: 19917751
J Infect Dis. 1998 Jun;177(6):1660-3
pubmed: 9607846
Cold Spring Harb Perspect Med. 2014 Nov 10;5(5):a019653
pubmed: 25384765
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:53-67
pubmed: 23137137
J Infect Dis. 2006 Oct 1;194(7):1008-18
pubmed: 16960790
Antimicrob Agents Chemother. 2005 Feb;49(2):638-42
pubmed: 15673745

Auteurs

Joseph Meletiadis (J)

Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Department of Medical Microbiology and Infectious Diseases, Erasmus MC, 3015 CN Rotterdam, The Netherlands.

Maria-Ioanna Beredaki (MI)

Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.

Antigoni Elefanti (A)

Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.

Spyros Pournaras (S)

Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.

Anouk Muller (A)

Department of Medical Microbiology and Infectious Diseases, Erasmus MC, 3015 CN Rotterdam, The Netherlands.
Department of Medical Microbiology, Haaglanden Medisch Centrum, 2512 VA The Hague, The Netherlands.

Classifications MeSH